ag 1879 has been researched along with Familial Primary Pulmonary Hypertension in 1 studies
3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine: Fyn kinase inhibitor
Familial Primary Pulmonary Hypertension: Familial or idiopathic hypertension in the PULMONARY CIRCULATION which is not secondary to other disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prewitt, AR | 1 |
| Ghose, S | 1 |
| Frump, AL | 1 |
| Datta, A | 1 |
| Austin, ED | 1 |
| Kenworthy, AK | 1 |
| de Caestecker, MP | 1 |
1 other study available for ag 1879 and Familial Primary Pulmonary Hypertension
| Article | Year |
|---|---|
Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Protein Receptors, Type II; Caveolae; Cave | 2015 |